This filing removes a contractual barrier to buybacks but does not commit the company to repurchasing shares. Monitor future filings for actual repurchase activity and the company's cash position, as the $20 million authorization represents a significant portion of the $32 million market cap. The stock's recent volatility and the company's history of name changes and capital structure changes warrant caution.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 9 $1.51entry
- T+1 · 2mo ago +3.31%α +3.91% · $1.56
- T+5 · 2mo ago +5.96%α +6.62% · $1.60
- T+20 · 7w ago −1.32%α −3.27% · $1.49
- T+52 · todayOpen
- T+60 · in 11d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SRX Global Inc. obtained consent from the holders of its Series C convertible preferred stock to implement a stock repurchase plan, allowing the company to buy back up to 10 million shares or 50% of outstanding common stock for up to $20 million through July 2027. This removes a contractual restriction from the August 2026 securities purchase agreement that had prohibited such repurchases, but does not change the company's underlying financial position or operations. The filing is a routine contractual amendment with no new financial data or operational updates.
Key Facts
- SRX Global entered into a Limited Consent and Amendment Agreement with holders of Series C convertible preferred stock on September 8, 2026.
- The consent allows SRXH to maintain a stock repurchase plan to buy back up to the lesser of 10 million shares or 50% of outstanding common stock, for up to $20 million, through July 7, 2027.
- The Series C preferred stock was issued on August 27, 2026, for $2.825 million (3,579 shares).
- The consent waives restrictions in the Securities Purchase Agreement and Certificate of Designations that had prohibited stock repurchases.
- The company will reimburse the holder's counsel $5,000 for costs related to the agreement.
Financial Impact
Authorizes up to $20 million in share repurchases, but no actual repurchases have been announced or executed.
Risk Factors
- The repurchase plan is authorized but not yet executed; no shares have been bought back.
- The company has a history of name changes (SRx Health Solutions, Better Choice Co Inc., Sport Endurance) and a small market cap ($32M), indicating potential volatility.
- The Series C preferred stock terms and the consent agreement may contain additional restrictions or conversion rights not fully detailed in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (SRXH), Batch item 1 | 0001493152-26-041945 |
| Exhibit: ex10-1.htm | 0001493152-26-041945 |
| Document: 0001493152-26-041945-index-headers.html | 0001493152-26-041945 |
| Document: 0001493152-26-041945-index.html | 0001493152-26-041945 |
Track record
30 reports on SRXH
4 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
- Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
- Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
- Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
- Sep 9, 202610w ago 8-K Neutral 3/10 Viewing Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
- Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
- Aug 28, 202612w ago 8-K Bearish 5/10 Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
- Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers